SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Astrazeneca Pharma I - Quaterly Results

14 Aug 2025 Evaluate
The Sales for the quarter ended June 2025 of Rs. 5263.10 millions rose by 35.81% from Rs. 3875.20 millions.The Total Profit for the quarter ended June 2025 of Rs. 558.30 millions grew from Rs.-117.90 millionsOP of the company witnessed a marginal growth to 923.50 millions from 464.20 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 5263.10 3875.20 35.81 5263.10 3875.20 35.81 17162.90 12955.30 32.48
Other Income 112.40 83.50 34.61 112.40 83.50 34.61 406.30 348.00 16.75
PBIDT 923.50 464.20 98.94 923.50 464.20 98.94 2946.00 2192.50 34.37
Interest 7.20 1.10 554.55 7.20 1.10 554.55 14.60 12.00 21.67
PBDT 912.70 -112.50 -911.29 912.70 -112.50 -911.29 1963.50 2344.80 -16.26
Depreciation 165.70 39.10 323.79 165.70 39.10 323.79 399.90 149.40 167.67
PBT 747.00 -151.60 -592.74 747.00 -151.60 -592.74 1563.60 2195.40 -28.78
TAX 188.70 -33.70 -659.94 188.70 -33.70 -659.94 406.20 580.30 -30.00
Deferred Tax -32.30 -141.20 -77.12 -32.30 -141.20 -77.12 -199.20 -9.00 2113.33
PAT 558.30 -117.90 -573.54 558.30 -117.90 -573.54 1157.40 1615.10 -28.34
Equity 50.00 50.00 0.00 50.00 50.00 0.00 50.00 50.00 0.00
PBIDTM(%) 17.55 11.98 46.48 17.55 11.98 46.48 17.16 16.92 1.43

Astrazeneca Pharma I Share Price

8567.20 -150.85 (-1.73%)
15-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.65
Dr. Reddys Lab 1218.30
Cipla 1226.65
Zydus Lifesciences 936.00
Lupin 2339.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×